Gadolinium-primarily based distinction brokers (GBCAs) are greatly Employed in magnetic resonance imaging (MRI) to improve the visibility of blood vessels, tumors, inflammation, along with other inner structures. Although normally regarded Risk-free, worries about GBCA toxicity have emerged over the past two decades—especially in individuals with